Q4 2024 Holdings
Filed 2025-02-14 | 47 holdings | $115.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $30.7M | 1,433,828 | 26.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $23.1M | 300,000 | 19.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $10.7M | 6,986,744 | 9.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $8.6M | 423,795 | 7.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $8.3M | 1,579,000 | 7.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $6.7M | 185,520 | 5.8% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.9M | 800,000 | 3.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.5M | 300,000 | 3.0% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $2.5M | 300,000 | 2.2% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $2.4M | 904,029 | 2.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.3M | 50,000 | 2.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.2M | 181,367 | 1.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.8M | 97,889 | 1.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $1.6M | 500,000 | 1.4% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $1.3M | 323,973 | 1.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.3M | 150,000 | 1.1% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $821.8K | 28,685 | 0.7% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $817.1K | 109,972 | 0.7% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $669.1K | 56,700 | 0.6% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $515.8K | 83,333 | 0.4% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $403.3K | 122,223 | 0.3% |
| Geron Corp(GERN) | COM | 374163103 | $173.5K | 49,000 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $160.8K | 13,000 | 0.1% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $110.6K | 70,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $107.3K | 40,500 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $104.0K | 55,000 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $94.5K | 90,000 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $94.2K | 17,000 | 0.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $76.7K | 35,000 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $74.8K | 13,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $69.7K | 18,000 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $67.8K | 75,000 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $67.0K | 27,000 | 0.1% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $65.4K | 70,000 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $55.7K | 10,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $55.2K | 30,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $52.9K | 35,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $42.4K | 80,000 | 0.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $36.1K | 35,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $33.3K | 35,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $27.1K | 40,000 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $26.8K | 50,000 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $25.3K | 45,000 | 0.0% |
| Cocrystal Pharma Inc(COCP) | COM NEW | 19188J409 | $20.2K | 10,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $19.3K | 25,000 | 0.0% |